Change of Company Secretary, Issue of Equity

RNS Number : 3303G

Craven House Capital PLC

22 July 2019

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

Craven House Capital plc

("Craven House" or the "Company")

Change of Company Secretary, Issue of Equity

Craven House Capital (AIM:CRV) announces the appointment of Ms. Tamra Spink as Company Secretary. Her predecessor, Mr. Brian Winters has stepped down from the role with effect from today.

The Company has allotted 14,400 ordinary shares of $1.00 in the capital of the Company ("Ordinary Shares") at a price of $12.50 per share to Mr. Brian Winters as settlement for company secretarial services provided by him since August 2016.

Application will be made for the admission to trading on AIM ("Admission") for the 14,400 new Ordinary Shares.  The new Ordinary Shares will rank pari passu in all respects with the existing Ordinary Shares of the Company.  Admission is expected at 8.00 a.m. on or around 26 July 2019.

Total Voting Rights

Following Admission, the Company's issued share capital will comprise 2,513,438 Ordinary Shares which may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.  The Company does not hold any shares in treasury.

~ Ends ~

For further information please contact:

Craven House Capital Plc Mark Pajak www.Cravenhousecapital.com	Tel:   [phone]
SI Capital Broker Nick Emerson www.sicapital.co.uk	Tel: [phone]
SPARK Advisory Partners Limited Nominated Adviser Matt Davis/Mark Brady www.Sparkadvisorypartners.com	Tel:   [phone]

About Craven House Capital:

The Company's Investing Policy is to invest in or acquire a portfolio of companies, partnerships, joint ventures, businesses or other assets globally in any geographic jurisdiction. The company will invest in both developed and developing markets providing long term patient capital and is often involved in special situations, restructuring, expansion and turn around investments in crisis and transitioning economies.

1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Mr Brian Winters
2	Reason for the notification
a)	Position/status	Company Secretary
b)	Initial notification / Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Craven House Capital Plc
b)	Legal Entity Identifier	2138008MJUBUX6WX9B72
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary Shares of $1.00 each GB00BD4FQ360
b)	Nature of the transaction	Issue of shares as part of salary
c)	Currency	GBP
d)	Price(s) and volume(s)	Price(s)	Volume(s)
		$12.50	14,400
e)	Aggregated information - Aggregated volume - Price - Aggregated total	N/A single transaction
f)	Date of the transaction	22 July 2019
g)	Place of the transaction	London Stock Exchange, AIM

 

END

 

 

MSCLLFEEDFIFFIA